TradingKey

關於 Avadel Pharmaceuticals PLC 公司

Avadel Pharmaceuticals PLC 是一家生物製藥公司。該公司的產品 LUMRYZ 是一種緩釋型羥基丁酸鈉，適用於睡前服用一次，用於治療成人發作性睡病患者的猝倒症或白天過度嗜睡 (EDS)。該公司的方法包括將解決方案應用於藥物開發，以解決患者面臨的治療選擇問題。該公司的藥物輸送技術包括 MICROPUMP、LIQUITIME 和 MEDUSA。其 MICROPUMP 技術可用於開發緩釋型固體口服劑型藥物。其 LIQUITIME 技術可用於開發液體懸浮液劑型的緩釋型口服產品，這可能使此類劑型特別適合兒童和/或吞嚥藥片或膠囊有困難的患者。其 MEDUSA 技術可用於開發緩釋型注射劑型藥物。

公司簡介

公司代碼AVDL

公司名稱Avadel Pharmaceuticals PLC

上市日期Jan 16, 1952

CEOMr. Gregory J. (Greg) Divis, Jr.

員工數量188

證券類型Ordinary Share

年結日Jan 16

公司地址Block 10-1 Blanchardstown Corporate Park

城市DUBLIN

上市交易所NASDAQ Global Market Consolidated

國家Ireland

郵編15

電話35319015201

網址https://www.avadel.com/

公司代碼AVDL

上市日期Jan 16, 1952

CEOMr. Gregory J. (Greg) Divis, Jr.

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Eric J. Ende, M.D.

Independent Director

219.90K

+5.27%

Mr. Peter J. Thornton

Independent Director

115.06K

+10.57%

Dr. Mark Anthony Mccamish, M.D., Ph.D.

Independent Director

89.03K

+14.10%

Mr. Thomas S. Mchugh

Chief Financial Officer

87.80K

-12.55%

Ms. Linda S. Palczuk

Independent Director

78.90K

+16.20%

Ms. Susan Rodriguez

Chief Operating Officer

--

Mr. Jerad Seurer

General Counsel and Corporate Secretary

--

Mr. Gregory J. (Greg) Divis, Jr.

Chief Executive Officer, Director

--

Dr. Naseem Amin, M.D.

Independent Director

--

Ms. Courtney Turiano

Investor Relations

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Eric J. Ende, M.D.

Independent Director

219.90K

+5.27%

Mr. Peter J. Thornton

Independent Director

115.06K

+10.57%

Dr. Mark Anthony Mccamish, M.D., Ph.D.

Independent Director

89.03K

+14.10%

Mr. Thomas S. Mchugh

Chief Financial Officer

87.80K

-12.55%

Ms. Linda S. Palczuk

Independent Director

78.90K

+16.20%

Ms. Susan Rodriguez

Chief Operating Officer

--

收入明細

單位: USD更新時間: 3月3日週一

FY2020

FY2019

業務USD

名稱

營收

佔比

Vazculep

10.43M

46.70%

Akovaz

9.54M

42.74%

Bloxiverz

2.20M

9.85%

Other

159.00K

0.71%

地區USD

名稱

營收

佔比

United States

22.33M

100.00%

Ireland

0.00

0.00%

業務

地區

業務USD

名稱

營收

佔比

Vazculep

10.43M

46.70%

Akovaz

9.54M

42.74%

Bloxiverz

2.20M

9.85%

Other

159.00K

0.71%

股東統計

更新時間: 5月17日週六

持股股東

股東類型

持股股東

佔比

Janus Henderson Investors

14.03%

Tontine Asset Management, LLC

6.32%

Brandes Investment Partners, L.P.

5.85%

The Vanguard Group, Inc.

5.74%

Two Seas Capital LP

5.10%

Other

62.95%

持股股東

佔比

Janus Henderson Investors

14.03%

Tontine Asset Management, LLC

6.32%

Brandes Investment Partners, L.P.

5.85%

The Vanguard Group, Inc.

5.74%

Two Seas Capital LP

5.10%

Other

62.95%

股東類型

持股股東

佔比

Investment Advisor/Hedge Fund

28.13%

Investment Advisor

26.80%

Hedge Fund

20.94%

Individual Investor

4.83%

Venture Capital

3.82%

Research Firm

2.59%

Pension Fund

0.47%

Bank and Trust

0.38%

Insurance Company

0.03%

Other

12.03%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

372

85.19M

87.92%

-22.67M

2025Q1

377

85.31M

88.05%

-24.78M

2024Q4

354

86.56M

89.59%

-16.46M

2024Q3

334

81.87M

84.98%

-15.41M

2024Q2

299

81.11M

84.30%

-2.77M

2024Q1

258

76.98M

80.25%

+5.42M

2023Q4

226

62.92M

70.15%

-3.93M

2023Q3

220

60.11M

69.62%

-5.86M

2023Q2

213

57.67M

66.98%

-1.24M

2023Q1

201

54.14M

84.38%

+9.93M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

Janus Henderson Investors

13.59M

14.03%

-487.88K

-3.47%

Mar 31, 2025

Tontine Asset Management, LLC

6.13M

6.32%

-203.28K

-3.21%

Mar 31, 2025

Brandes Investment Partners, L.P.

5.67M

5.85%

+3.49M

+160.78%

Mar 31, 2025

The Vanguard Group, Inc.

3.88M

4.01%

-52.69K

-1.34%

Mar 31, 2025

Two Seas Capital LP

4.95M

5.1%

+650.00K

+15.13%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

4.69M

4.84%

-55.04K

-1.16%

Mar 31, 2025

Polar Capital LLP

4.36M

4.5%

-58.24K

-1.32%

Mar 31, 2025

Kotler (Kevin)

3.72M

3.84%

-1.01M

-21.37%

Feb 12, 2024

Vivo Capital, LLC

2.68M

2.77%

--

Mar 31, 2025

Wealth Effects LLC

2.37M

2.44%

+24.99K

+1.07%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

Invesco Pharmaceuticals ETF

2.64%

iShares Neuroscience and Healthcare ETF

1.92%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.11%

Invesco Nasdaq Biotechnology ETF

0.1%

ProShares Ultra Nasdaq Biotechnology

0.1%

Nuveen ESG Small-Cap ETF

0.07%

Fidelity Enhanced Small Cap ETF

0.07%

iShares MSCI USA Small-Cap Min Vol Factor ETF

0.06%

Federated Hermes MDT Small Cap Core ETF

0.05%

JPMorgan BetaBuilders US Small Cap Equity ETF

0.05%

Invesco Pharmaceuticals ETF

佔比2.64%

iShares Neuroscience and Healthcare ETF

佔比1.92%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.11%

Invesco Nasdaq Biotechnology ETF

佔比0.1%

ProShares Ultra Nasdaq Biotechnology

佔比0.1%

Nuveen ESG Small-Cap ETF

佔比0.07%

Fidelity Enhanced Small Cap ETF

佔比0.07%

iShares MSCI USA Small-Cap Min Vol Factor ETF

佔比0.06%

Federated Hermes MDT Small Cap Core ETF

佔比0.05%

JPMorgan BetaBuilders US Small Cap Equity ETF

佔比0.05%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Avadel Pharmaceuticals PLC

11.145USD

Avadel Pharmaceuticals PLC

11.145

概覽

公司

財務